Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma
US FDA recently approved rituximab biosimilar as monotherapy and in combination with chemotherapy.
All articles by Leah Lawrence
Opioid Epidemic Response May Be Limiting Cancer-Related Pain Management
A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients’ ability to manage their pain.
Breast Cancer Follow-Up Care Recommendations: Considerations for a Growing Survivorship Population
Women with a history of breast cancer face a wide variety of challenges as they transition from the role of “patient” to “survivor”.
Next post in Breast Cancer
